Neurotrack

Neurotrack, based in Palo Alto, CA, is dedicated to enhancing cognitive screening through its clinically trusted and FDA-registered digital tools, which facilitate timely detection of mild cognitive impairment and dementia. With a focus on improving patient outcomes and care coordination, Neurotrack's solutions integrate seamlessly into various healthcare settings, ensuring efficient and standardized cognitive assessments.

Since its inception in 2012, Neurotrack has grown to support over 15,000 providers nationwide, driven by a mission to detect cognitive decline early and improve overall healthcare quality. Their technology, endorsed by 375 peer-reviewed publications, empowers healthcare teams with actionable insights while aligning with value-based care models.

Generated from the website